ISPOR CEO Rob Abbott on HTA-integrated trial design, digital twin evidence gaps, SaMD’s continuous update problem, and the one change he’d mandate for clinical tech.
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
- Is It Time To Replace RECIST — Or Just Add AI?
- Clinical Research Has System Sprawl Problem
- How Clinical Trial Sites Must Adapt To The Predictive Analytics Era
- Why Patients Drop Out And How To Stop Them
- Predictive Analytics Is Reshaping How Sponsors Run Clinical Trials
- AI In Clinical Trials: Real Impact, Real Limits, What's Next
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
The Power Of A Collaboration Platform
Using a recent Phase III Endocrinology trial as a primary case study, this article illustrates the qualitative shift from administrative burden to strategic oversight.
-
Providing Drug Supply Support In Complex Environments Through IRT
Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
Phase 4 Trials: A Critical Component Of Post-Marketing Insight
Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.
-
What's Driving Data Innovation: Notes From The Front Lines Of Change
Clinical data innovators prioritize risk-based quality management, standards, and closer collaboration with research sites. Many see AI as an important support rather than a top priority.
-
The Future Of Clinical Trials Rests On A Unified CTMS Platform
Discover why a unified CTMS platform is the answer for managing both the clinical trial itself and the data it produces when it comes to poorly integrated clinical trial management systems (CTMS).
-
eTMFs Uncovered: 5 Costly Misconceptions To Avoid
Critically examine prevalent myths surrounding electronic Trial Master Files (eTMFs) and their integration with electronic Investigator Site Files (eISFs).
-
Advancements In Digital Health Applications In Clinical Trials
Reflecting on the past year, take time to review the significant strides the digital health industry has made, especially in digital measures for clinical research.
-
5 Features to Look for in Your Next eTMF
Not every electronic trial master file will provide the robust support and compliance measures required. When searching for a successful solution, make sure the eTMF of interest has these five features.
-
eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs
Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.
-
Headed Down Registry Road? Here Are The EDC Features You'll Need
Most of us rely on electronic data capture (EDC) to help us reach our study destination. How do we choose the EDC "vehicle" that will get us there safely, with minimal delays? Consider the relative importance of these key EDC features.
RECENT NEWSLETTERS
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More
- 04.09.26 -- AI In Clinical Trials: Recruitment, eCOA Risks & Data
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up